Search

CN-122005660-A - Pharmaceutical composition for improving egg laying performance and egg laying quality of poultry, and preparation method and application thereof

CN122005660ACN 122005660 ACN122005660 ACN 122005660ACN-122005660-A

Abstract

The invention discloses a pharmaceutical composition for improving egg laying performance and egg laying quality of poultry, a preparation method and application thereof, and belongs to the technical field of poultry cultivation. The pharmaceutical composition comprises, by mass, 15-30 parts of semiaquilegia root, 10-25 parts of herba lycopodii, 20-25 parts of cortex acanthopanacis, 10-20 parts of pericarpium trichosanthis, 15-30 parts of luffa, 10-30 parts of cortex albiziae, 20-40 parts of hesperidin, 15-30 parts of jerusalem artichoke powder and 15-30 parts of glycerinum saccharate. The pharmaceutical composition can obviously improve the intestinal tracts of the laying fowl, promote nutrient digestion and absorption, increase calcium and phosphorus absorption and deposition, improve the quality of eggs, and reduce the feed-egg ratio, thereby having important application prospect and value in the technical field of health products of the laying fowl.

Inventors

  • LV YANG
  • LIU WENLI
  • LV QINGLIN
  • LIU SHUHE

Assignees

  • 河南森隆兽药有限公司
  • 河南森隆动物保健品有限公司

Dates

Publication Date
20260512
Application Date
20260211

Claims (10)

  1. 1. The pharmaceutical composition for improving the egg laying performance and the egg laying quality of the poultry is characterized by comprising the following raw materials in parts by mass: 15-30 parts of radix semiaquilegiae, 10-25 parts of herba lycopodii, 20-25 parts of cortex acanthopanacis, 10-20 parts of pericarpium trichosanthis, 15-30 parts of luffa, 10-30 parts of cortex albiziae, 20-40 parts of hesperidin, 15-30 parts of jerusalem artichoke powder and 15-30 parts of glycerinum saccharate.
  2. 2. The pharmaceutical composition according to claim 1, wherein the pharmaceutical composition comprises the following raw materials in parts by mass: 15 parts of radix semiaquilegiae, 10 parts of herba lycopodii, 20 parts of cortex acanthopanacis, 10 parts of snakegourd peel, 15 parts of luffa, 10 parts of cortex albiziae, 20 parts of hesperidin, 15 parts of jerusalem artichoke powder and 15 parts of glycerinum sucrose.
  3. 3. The pharmaceutical composition according to claim 1, wherein the pharmaceutical composition comprises the following raw materials in parts by mass: 25 parts of radix semiaquilegiae, 15 parts of herba lycopodii, 22 parts of cortex acanthopanacis, 15 parts of snakegourd peel, 20 parts of luffa, 20 parts of cortex albiziae, 30 parts of hesperidin, 25 parts of jerusalem artichoke powder and 20 parts of glycerinum sucrose.
  4. 4. The pharmaceutical composition according to claim 1, wherein the pharmaceutical composition comprises the following raw materials in parts by mass: 30 parts of radix semiaquilegiae, 25 parts of herba lycopodii, 25 parts of cortex acanthopanacis, 20 parts of snakegourd peel, 30 parts of luffa, 30 parts of cortex albiziae, 40 parts of hesperidin, 30 parts of jerusalem artichoke powder and 30 parts of glycerinum sucrose.
  5. 5. The pharmaceutical composition according to claim 1, wherein the pharmaceutical composition comprises the following raw materials in parts by mass: 20 parts of radix semiaquilegiae, 25 parts of herba lycopodii, 25 parts of cortex acanthopanacis, 10 parts of snakegourd peel, 15 parts of luffa, 15 parts of cortex albiziae, 25 parts of hesperidin, 25 parts of jerusalem artichoke powder and 15 parts of glycerinum sucrose.
  6. 6. The method for preparing the pharmaceutical composition according to any one of claims 1 to 5, characterized by comprising the following steps: Respectively crushing radix semiaquilegiae, herba Salviae chinensis, cortex acanthopanacis, pericarpium trichosanthis, retinervus luffae fructus and cortex albiziae, sieving with a 100-mesh sieve, mixing according to the formula amount, stirring for 5-10 minutes to be uniform to obtain traditional Chinese medicine mixed powder, weighing the formula amount of hesperidin, jerusalem artichoke powder and glyceride saccharate, stirring for 5-10 minutes to be uniform, then adding into the traditional Chinese medicine mixed powder, and stirring to be uniform to obtain the pharmaceutical composition.
  7. 7. Use of the pharmaceutical composition according to any one of claims 1 to 5 for improving the egg laying performance, egg laying quality, immunity performance, digestibility performance or reproductive performance of poultry.
  8. 8. The use of claim 7, wherein the poultry comprises chickens, ducks, geese, pigeons and quails.
  9. 9. A method for improving egg laying performance and egg laying quality of poultry is characterized by comprising the step of adding the pharmaceutical composition according to any one of claims 1-5 to poultry feed in a period from egg laying to egg laying elimination.
  10. 10. The method for improving the egg laying performance and the egg laying quality of poultry according to claim 9, wherein the addition amount of the pharmaceutical composition is 0.5-2 kg/ton.

Description

Pharmaceutical composition for improving egg laying performance and egg laying quality of poultry, and preparation method and application thereof Technical Field The invention belongs to the technical field of poultry cultivation, and particularly relates to a pharmaceutical composition for improving egg laying performance and egg laying quality of poultry, and a preparation method and application thereof. Background The egg laying performance and the egg laying quality are important indexes in the egg-laying poultry production, and are the manifestations of good and bad economic benefits of the egg-laying poultry. The decline of egg laying performance and the low quality of eggs are mainly affected by physiological factors (such as age of day, variety and the like), environmental factors (such as illumination, temperature, humidity, noise, stress and the like), feed factors (such as poor quality, improper calcium-phosphorus ratio, nutrition deficiency, nutrition excess, unbalanced nutrition and the like), disease factors (such as virus diseases, bacterial diseases, parasitic diseases and the like). At present, the problems of reduced laying rate or short peak period duration, low quality of eggs and the like of the eggs occur in various places, and comprehensive treatment and preventive measures are required because of a plurality of pathogenesis and induction factors of the diseases. At present, the most commonly used disease is drug treatment, but antiviral drugs (such as ribavirin, amantadine and virucide) are forbidden, and various antibacterial drugs and antiparasitic drugs are repeatedly used for a long time, so that pathogenic microorganisms generate drug resistance to the drugs, the curative effect is reduced, the drugs remain in animal bodies and eggs, the quality of the drugs cannot meet pollution-free requirements, and the export of egg products and the physical health of people are affected. With the improvement of the living standard of people, the requirements on food are higher and higher, eggs are the most common choice for people to supplement protein, the requirements on the quality and taste of the eggs are higher and higher, and more people are willing to consume high-quality safe organic eggs. Poor eggshell quality is also an important problem in the egg industry all the time, so that not only is the economic benefit of egg poultry cultivation reduced, but also the transportation and storage of eggs are affected, and the hatching rate of egg poultry is greatly affected, because the eggshell can protect embryos from the harmful effects of external environment. Because broken eggs and malformed eggs are easy to infect pathogenic bacteria, the quality of eggshells has a great influence on consumers. In order to improve or enhance the laying rate of the egg-laying fowl and the quality of the egg-laying fowl, various medicines and additives are appeared on the market. The products are mainly chemical drugs, traditional Chinese medicines, vitamins, minerals and amino acid products, and although chemical drugs can improve the problem of low laying rate of the egg-laying fowl, the chemical drugs have great toxic and side effects, and more serious, the drugs remain in the body of the egg-laying fowl or in eggs and cannot ensure the health of foods. Although the traditional Chinese medicine product has no toxic or side effect and medicine residue, the traditional Chinese medicine product has limited clinical application for improving the laying rate of the egg-laying fowl and the quality of the egg-laying fowl due to unreasonable prescription or poor curative effect and the like. The vitamin, mineral and amino acid products are not ideal for the egg-laying fowl in a disease state or sub-health state due to the supplement of the additive, and can only show effect when the egg-laying fowl is in the shortage of the additive. Disclosure of Invention The invention provides a pharmaceutical composition for improving egg laying performance and egg laying quality of poultry, which comprises the following raw materials in parts by mass: 15-30 parts of radix semiaquilegiae, 10-25 parts of herba lycopodii, 20-25 parts of cortex acanthopanacis, 10-20 parts of pericarpium trichosanthis, 15-30 parts of luffa, 10-30 parts of cortex albiziae, 20-40 parts of hesperidin, 15-30 parts of jerusalem artichoke powder and 15-30 parts of glycerinum saccharate. In a specific embodiment, the pharmaceutical composition comprises the following raw materials in parts by mass: 15 parts of radix semiaquilegiae, 10 parts of herba lycopodii, 20 parts of cortex acanthopanacis, 10 parts of snakegourd peel, 15 parts of luffa, 10 parts of cortex albiziae, 20 parts of hesperidin, 15 parts of jerusalem artichoke powder and 15 parts of glycerinum sucrose. In a specific embodiment, the pharmaceutical composition comprises the following raw materials in parts by mass: 25 parts of radix semiaquilegiae, 15 parts of herba lycopodii, 22 part